These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22935809)

  • 1. Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis.
    Quesnel AM; Seton M; Merchant SN; Halpin C; McKenna MJ
    Otol Neurotol; 2012 Oct; 33(8):1308-14. PubMed ID: 22935809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up.
    Jan TA; Remenschneider AK; Halpin C; Seton M; McKenna MJ; Quesnel AM
    Laryngoscope Investig Otolaryngol; 2017 Oct; 2(5):262-268. PubMed ID: 29094069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Incidence and Degree of Sensorineural Hearing Loss in Otosclerosis.
    Ishai R; Halpin CF; Shin JJ; McKenna MJ; Quesnel AM
    Otol Neurotol; 2016 Dec; 37(10):1489-1496. PubMed ID: 27755362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis, Otology & Neurotology 33:1308-1314, 2012.
    Brookler KH; Gilston N
    Otol Neurotol; 2013 Jun; 34(4):778-9. PubMed ID: 23370569
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical treatment of otosclerosis: rationale for use of bisphosphonates.
    Brookler K
    Int Tinnitus J; 2008; 14(2):92-6. PubMed ID: 19205157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Audiometric Assessment of the Effectiveness of Surgical Treatment of Otosclerosis Depending on the Preoperative Incidence of Carhart's Notch.
    Job K; Wiatr A; Skladzien J; Wiatr M
    Ear Nose Throat J; 2024 Apr; 103(4):241-247. PubMed ID: 34633243
    [No Abstract]   [Full Text] [Related]  

  • 7. Audiometric analyses confirm a cochlear component, disproportional to age, in stapedial otosclerosis.
    Topsakal V; Fransen E; Schmerber S; Declau F; Yung M; Gordts F; Van Camp G; Van de Heyning P
    Otol Neurotol; 2006 Sep; 27(6):781-7. PubMed ID: 16885785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation.
    Derks W; De Groot JA; Raymakers JA; Veldman JE
    Acta Otolaryngol; 2001 Jan; 121(2):174-7. PubMed ID: 11349772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Reid DM; Devogelaer JP; Saag K; Roux C; Lau CS; Reginster JY; Papanastasiou P; Ferreira A; Hartl F; Fashola T; Mesenbrink P; Sambrook PN;
    Lancet; 2009 Apr; 373(9671):1253-63. PubMed ID: 19362675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review of the Effectiveness of Bisphosphonates for Otosclerosis.
    Patel S; Walters B; Eastwood M; Abou-Foul AK; Bhimrao S
    Otol Neurotol; 2022 Jun; 43(5):530-537. PubMed ID: 35213475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progressive sensorineural hearing loss in cochlear otosclerosis].
    Sellari-Franceschini S; Ravecca F; De Vito A; Berrettini S
    Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):59-65. PubMed ID: 10205935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of etidronate disodium on progressive hearing loss from otosclerosis.
    Kennedy DW; Hoffer ME; Holliday M
    Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 1):461-7. PubMed ID: 8414563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochlear implantation in patients with otosclerosis of the otic capsule.
    Burmeister J; Rathgeb S; Herzog J
    Am J Otolaryngol; 2017; 38(5):556-559. PubMed ID: 28549773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the improvement in bone conduction threshold after stapedectomy.
    García-Iza L; Navarro JJ; Goiburu M; Pérez N; Altuna X
    Acta Otorrinolaringol Esp; 2016; 67(5):268-74. PubMed ID: 26971342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical findings and long-term hearing results in 3,050 stapedotomies for primary otosclerosis: a prospective study with the otology-neurotology database.
    Vincent R; Sperling NM; Oates J; Jindal M
    Otol Neurotol; 2006 Dec; 27(8 Suppl 2):S25-47. PubMed ID: 16985478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stapedectomy for far-advanced otosclerosis.
    Shea PF; Ge X; Shea JJ
    Am J Otol; 1999 Jul; 20(4):425-9. PubMed ID: 10431881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detrimental effect of aminohydroxypropylidene bisphosphonate (APD) in otospongiosis.
    Boumans LJ; Poublon RM
    Eur Arch Otorhinolaryngol; 1991; 248(4):218-21. PubMed ID: 1859654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of sensorineural hearing loss in patients with unilateral safe chronic suppurative otitis media.
    Singer AEA; Abdel-Naby Awad OG; El-Kader RMA; Mohamed AR
    Am J Otolaryngol; 2018; 39(2):88-93. PubMed ID: 29331307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography and otosclerosis: a practical method to correlate the sites affected to hearing loss.
    Wycherly BJ; Berkowitz F; Noone AM; Kim HJ
    Ann Otol Rhinol Laryngol; 2010 Dec; 119(12):789-94. PubMed ID: 21250549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.